• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扩散加权成像-组织学:确定肝纤维化程度的一种可能方法?

DWI - histology: a possible means of determining degree of liver fibrosis?

作者信息

Verloh Niklas, Utpatel Kirsten, Haimerl Michael, Zeman Florian, Fellner Claudia, Dahlke Marc, Renner Philipp, Seyfried Timo, Müller Martina, Stroszczynski Christian, Evert Matthias, Wiggermann Philipp

机构信息

Department of Radiology, University Hospital Regensburg, Regensburg, Germany.

Department of Pathology, University Regensburg, Regensburg, Germany.

出版信息

Oncotarget. 2018 Apr 13;9(28):20112-20118. doi: 10.18632/oncotarget.24981.

DOI:10.18632/oncotarget.24981
PMID:29732007
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5929450/
Abstract

OBJECTIVES

The aim of this study was to determine the diagnostic value of diffusion-weighted MRI of the liver at 3T to classify liver fibrosis/cirrhosis.

METHODS

62 patients who underwent both histopathological examination and diffusion-weighted imaging of the liver via 3T MRI within a period of 3 months were included in the study. The Ishak score (1-6) was used to determine the degree of fibrosis: No liver fibrosis (NLF; Ishak 0, n = 16), mild liver fibrosis (MLF; Ishak 1-2, n = 23), advanced liver fibrosis (ALF; Ishak 3-5, n = 12), and liver cirrhosis (LC; Ishak 6, n = 11).

RESULTS

The corresponding ADC values for the individual patient groups were as follows: NLF: 1123 (SD 95.8); MLF: 1032 (SD 77.6); ALF: 962 (SD 68.8); LC: 1015 (SD 60.2) mm2/s. There is a significant difference between NLF and MLF (p = 0.004) and between MLF and ALF (p = 0.022). A significant difference between patients with ALF and LC (p = 0.117) could not be found.

CONCLUSION

Liver fibrosis/cirrhosis lowers the ADC values of the liver parenchyma in 3T MRI. However, the degree of fibrosis can only be conditionally determined on the basis of ADC values.

摘要

目的

本研究旨在确定3T磁共振成像(MRI)肝脏扩散加权成像对肝纤维化/肝硬化进行分类的诊断价值。

方法

本研究纳入62例在3个月内同时接受肝脏组织病理学检查和3T MRI肝脏扩散加权成像的患者。采用Ishak评分(1 - 6分)确定纤维化程度:无肝纤维化(NLF;Ishak 0分,n = 16)、轻度肝纤维化(MLF;Ishak 1 - 2分,n = 23)、重度肝纤维化(ALF;Ishak 3 - 5分,n = 12)和肝硬化(LC;Ishak 6分,n = 11)。

结果

各患者组对应的表观扩散系数(ADC)值如下:NLF:1123(标准差95.8);MLF:1032(标准差77.6);ALF:962(标准差68.8);LC:1015(标准差60.2)mm²/s。NLF与MLF之间(p = 0.004)以及MLF与ALF之间(p = 0.022)存在显著差异。未发现ALF与LC患者之间存在显著差异(p = 0.117)。

结论

肝纤维化/肝硬化会降低3T MRI中肝实质的ADC值。然而,仅根据ADC值只能有条件地确定纤维化程度。

相似文献

1
DWI - histology: a possible means of determining degree of liver fibrosis?扩散加权成像-组织学:确定肝纤维化程度的一种可能方法?
Oncotarget. 2018 Apr 13;9(28):20112-20118. doi: 10.18632/oncotarget.24981.
2
Diagnostic Accuracy of Indocyanine Green Clearance Test for Different Stages of Liver Fibrosis and Cirrhosis.吲哚菁绿清除试验对不同阶段肝纤维化和肝硬化的诊断准确性
Diagnostics (Basel). 2023 Aug 12;13(16):2663. doi: 10.3390/diagnostics13162663.
3
Assessment of Liver Fibrosis with Diffusion-Weighted Magnetic Resonance Imaging Using Different b-values in Chronic Viral Hepatitis.在慢性病毒性肝炎中使用不同b值的扩散加权磁共振成像评估肝纤维化
Med Princ Pract. 2015;24(6):522-6. doi: 10.1159/000434682. Epub 2015 Jul 16.
4
Diffusion-weighted magnetic resonance imaging for staging liver fibrosis is less reliable in the presence of fat and iron.弥散加权磁共振成像在存在脂肪和铁的情况下对肝纤维化分期的可靠性较低。
Eur Radiol. 2013 May;23(5):1281-7. doi: 10.1007/s00330-012-2700-2. Epub 2012 Nov 9.
5
Feasibility of diagnosing and staging liver fibrosis with diffusion weighted imaging.利用扩散加权成像诊断肝纤维化及进行分期的可行性
Chin Med Sci J. 2008 Sep;23(3):183-6. doi: 10.1016/s1001-9294(09)60036-5.
6
Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis.弥散加权 MRI 评估肝纤维化和肝硬化的价值。
AJR Am J Roentgenol. 2009 Dec;193(6):1556-60. doi: 10.2214/AJR.09.2436.
7
The value of liver and spleen ADC measurements in the diagnosis and follow up of hepatic fibrosis in chronic liver disease.肝脏和脾脏表观扩散系数(ADC)测量在慢性肝病肝纤维化诊断及随访中的价值
Acta Clin Belg. 2014 Dec;69(6):426-32. doi: 10.1179/2295333714Y.0000000062. Epub 2014 Aug 7.
8
Diffusion-weighted magnetic resonance imaging for the assessment of liver fibrosis in chronic viral hepatitis.弥散加权磁共振成像在慢性病毒性肝炎肝纤维化评估中的应用。
PLoS One. 2021 Mar 4;16(3):e0248024. doi: 10.1371/journal.pone.0248024. eCollection 2021.
9
T2 relaxation time is related to liver fibrosis severity.T2弛豫时间与肝纤维化严重程度相关。
Quant Imaging Med Surg. 2016 Apr;6(2):103-14. doi: 10.21037/qims.2016.03.02.
10
Liver Apparent Diffusion Coefficient Changes during Telaprevir-Based Therapy for Chronic Hepatitis C.基于替拉瑞韦治疗慢性丙型肝炎期间肝脏表观扩散系数的变化
Balkan Med J. 2016 Nov;33(6):602-606. doi: 10.5152/balkanmedj.2016.151082. Epub 2016 Nov 1.

本文引用的文献

1
Diffusion-weighted imaging (DWI) of hepatocellular carcinomas: a retrospective analysis of the correlation between qualitative and quantitative DWI and tumour grade.肝细胞癌的扩散加权成像(DWI):DWI定性和定量与肿瘤分级相关性的回顾性分析
Clin Radiol. 2017 Jun;72(6):465-472. doi: 10.1016/j.crad.2016.12.017. Epub 2017 Jan 19.
2
DWI/ADC in Differentiation of Benign from Malignant Focal Liver Lesion.扩散加权成像/表观扩散系数在肝脏局灶性病变良恶性鉴别中的应用
Acta Inform Med. 2016 Jul 16;24(4):244-247. doi: 10.5455/aim.2016.24.244-247.
3
Liver fibrosis and Gd-EOB-DTPA-enhanced MRI: A histopathologic correlation.
肝纤维化与Gd-EOB-DTPA增强磁共振成像:组织病理学相关性
Sci Rep. 2015 Oct 19;5:15408. doi: 10.1038/srep15408.
4
Liver fibrosis: histopathologic and biochemical influences on diagnostic efficacy of hepatobiliary contrast-enhanced MR imaging in staging.肝纤维化:对肝胆对比增强磁共振成像分期诊断效能的组织病理学和生化影响。
Radiology. 2013 Nov;269(2):460-8. doi: 10.1148/radiology.13122482. Epub 2013 Jul 22.
5
Liver fibrosis: noninvasive assessment with acoustic radiation force impulse elastography--comparison with FibroScan M and XL probes and FibroTest in patients with chronic liver disease.肝纤维化:声辐射力脉冲弹性成像的无创评估——与 FibroScan M 和 XL 探头及 FibroTest 在慢性肝病患者中的比较。
Radiology. 2013 Oct;269(1):283-92. doi: 10.1148/radiol.13122208. Epub 2013 Apr 29.
6
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study.富马酸替诺福韦二吡呋酯治疗慢性乙型肝炎时肝硬化的逆转:一项 5 年开放标签随访研究。
Lancet. 2013 Feb 9;381(9865):468-75. doi: 10.1016/S0140-6736(12)61425-1. Epub 2012 Dec 10.
7
Intra- and interoperator reproducibility of acoustic radiation force impulse (ARFI) elastography--preliminary results.声辐射力脉冲(ARFI)弹性成像的内-操作者和间-操作者可重复性——初步结果。
Ultrasound Med Biol. 2012 Jul;38(7):1103-8. doi: 10.1016/j.ultrasmedbio.2012.02.032. Epub 2012 May 12.
8
MR prediction of liver fibrosis using a liver-specific contrast agent: Superparamagnetic iron oxide versus Gd-EOB-DTPA.磁共振肝纤维化成像对比剂选择:超顺磁性氧化铁与钆塞酸二钠。
J Magn Reson Imaging. 2012 Sep;36(3):664-71. doi: 10.1002/jmri.23691. Epub 2012 Apr 24.
9
Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta-analysis.声辐射力脉冲成像技术在肝纤维化分期中的应用性能:荟萃分析。
J Viral Hepat. 2012 Feb;19(2):e212-9. doi: 10.1111/j.1365-2893.2011.01537.x. Epub 2011 Oct 30.
10
Utility of diffusion-weighted imaging in the evaluation of liver fibrosis.弥散加权成像在肝纤维化评估中的应用。
Eur Radiol. 2012 Mar;22(3):682-7. doi: 10.1007/s00330-011-2295-z. Epub 2011 Oct 9.